Cargando…

Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up

A long-term follow-up (LTFU) of the nine-valent human papillomavirus (9vHPV) vaccine efficacy study in young women aged 16–26 years was initiated to evaluate if vaccine effectiveness for up to 14 years post-vaccination will remain above 90%. Vaccine effectiveness is measured as percent reduction in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kjaer, Susanne K., Nygård, Mari, Sundström, Karin, Munk, Christian, Berger, Sophie, Dzabic, Mensur, Fridrich, Katrin Elisabeth, Waldstrøm, Marianne, Sørbye, Sveinung Wergeland, Bautista, Oliver, Group, Thomas, Luxembourg, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018381/ https://www.ncbi.nlm.nih.gov/pubmed/33326342 http://dx.doi.org/10.1080/21645515.2020.1839292

Ejemplares similares

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries
por: Kjaer, Susanne K., et al.
Publicado: (2020)

Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up
por: Olsson, Sven-Eric, et al.
Publicado: (2020)

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial
por: Thiem, Vu Dinh, et al.
Publicado: (2021)

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
por: Garland, Suzanne M., et al.
Publicado: (2022)

May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia?
por: Skjeldestad, Finn Egil, et al.
Publicado: (2023)

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types
por: Nolan, Katrina M., et al.
Publicado: (2023)

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
por: Serrano, Beatriz, et al.
Publicado: (2012)

Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study
por: Thomsen, Louise T, et al.
Publicado: (2020)

Triage of Women with Minor Cervical Lesions: Data Suggesting a “Test and Treat” Approach for HPV E6/E7 mRNA Testing
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2010)

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women
por: Brown, Darron R., et al.
Publicado: (2022)

Welcome to Herpesviridae -- a new premier virology journal
por: Dzabic, Mensur, et al.
Publicado: (2010)

5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions
por: Westre, Bjørn, et al.
Publicado: (2016)

Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women—A cohort study
por: Westre, Bjørn, et al.
Publicado: (2019)

HPV E6/E7 mRNA Testing Is More Specific than Cytology in Post-Colposcopy Follow-Up of Women with Negative Cervical Biopsy
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

Ulcerative colitis: functional analysis of the in-depth proteome
por: Schniers, Armin, et al.
Publicado: (2019)

Risk of Intraepithelial Neoplasia Grade 3 or Worse (CIN3+) among Women Examined by a 5-Type HPV mRNA Test during 2003 and 2004, Followed through 2015
por: Rad, Amir, et al.
Publicado: (2023)

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2017)

HPV mRNA Is More Specific than HPV DNA in Triage of Women with Minor Cervical Lesions
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2014)

Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2016)

Interim Report
por: SSC. Central Design Group. USA
Publicado: (1985)

Intention-to-prevent analyses for estimating human papillomavirus vaccine efficacy in clinical studies
por: Saah, Alfred, et al.
Publicado: (2017)

13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25–33 Years with Minor Cytological Abnormalities–6 Years of Follow-Up
por: Rad, Amir, et al.
Publicado: (2023)

Reinfection of Nine-Valent Human Papillomavirus Vaccine Types Among HIV-Negative Men Who Have Sex With Men: A Prospective Cohort Study
por: Liu, Lirong, et al.
Publicado: (2022)

Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2017)

Can an inadequate cervical cytology sample in ThinPrep be converted to a satisfactory sample by processing it with a SurePath preparation?
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2017)

Real-life evaluation of histologic scores for Ulcerative Colitis in remission
por: Arkteg, Christian Børde, et al.
Publicado: (2021)

Risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) among women with HPV-test in 1990–1992, a 30-year follow-up study
por: Riibe, Marit Østlyngen, et al.
Publicado: (2021)

Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology
por: Al-Shibli, Khalid, et al.
Publicado: (2022)

Scandinavian modern
por: Englund, Magnus

Scandinavian festival
Publicado: (1989)

The Scandinavian POOH
por: Dahl-Jensen, Erik
Publicado: (1972)

Scandinavian Studies
por: Boyd, John
Publicado: (1889)

Scandinavians in Britain
Publicado: (1952)

Long-Term Exposure to Transportation Noise and Risk of Incident Stroke: A Pooled Study of Nine Scandinavian Cohorts
por: Roswall, Nina, et al.
Publicado: (2021)

Long-Term Exposure to Transportation Noise and Ischemic Heart Disease: A Pooled Analysis of Nine Scandinavian Cohorts
por: Pyko, Andrei, et al.
Publicado: (2023)

HPV types in cervical cancer tissue in South Africa: A head-to-head comparison by mRNA and DNA tests
por: Rad, Amir, et al.
Publicado: (2017)

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
por: Nygård, Mari, et al.
Publicado: (2020)

The Radesyge, or the Scandinavian Syphiloid Disease, Delineated from Scandinavian Sources of Information
Publicado: (1837)

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
por: Moreira, E. D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1nmrgsnbnv4dvq7vr3ha0sfj2t